MedTrace Logo

Hippotherapy and Parkinson's Disease

NCT02460796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2015-06-03

No results posted yet for this study

Summary

BACKGROUND: Motor symptoms associated with Parkinson's disease may impair one's independence and ability to perform daily activities consequently decreases quality of life. Hippotherapy has been shown as an effective treatment to improve function in daily activities and quality of life in other neurological populations, thus a study was conducted to assess the effects of hippotherapy in people with Parkinson's disease.

METHODS: Nine volunteers formed the treatment group which participated in a ten-week hippotherapy program, and nine individuals formed the control group (attended a ten-week series of lessons on Parkinson's disease). Outcome measures included 30-second chair stand (as a measure of strength-endurance), gait velocity (during 10m walk test) and health-related quality of life.

Conditions

Interventions

OTHER

Hippotherapy

The sessions began with a 5 minutes warm up that involved stretching and body awareness exercises. Then, the training was conducted for 20 minutes with arms and torso exercises, changes of direction called serpentine movements; up and down hip movements with feet on stirrups, and forced expiration. In the final 5 minutes, exercises for relaxation were conducted with the horse which involved moving the hand on the horse's neck, laying forward on the head and stroking the horse. The horses walking speed was between 5.8 and 6.4 Km/h.

Sponsors & Collaborators

  • Wilfrid Laurier University

    collaborator OTHER

  • University of Brasilia

    lead OTHER

Principal Investigators

  • Rita C Homem, MSc · UnB

  • Ricardo J Oliveira, PhD · UnB

Eligibility

Min Age
65 Years
Max Age
83 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-09-30
Completion
2013-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02460796 on ClinicalTrials.gov